Dia 08/11, a partir das 20h, tem ONCO Club.

Nosso time de especialistas vai debater sobre “Para quais pacientes com câncer de rim devemos oferecer adjuvância?

buy periactin online in the best USA pharmacy https://childrens-dentistry.com/uploads/media/wow/buy-periactin.html no prescription with fast delivery drugstore
buy ventolin inhaler online in the best USA pharmacy http://miamihealth.com/downloads/html/buy-ventolin-inhaler.html no prescription with fast delivery drugstore

“.

Para participar, CLIQUE AQUI.

Coordenação: Deusdedit Cortez Neto
Moderação: Maurício Dener Cordeiro

Parte 1 Journal Club

Estudo 1 – Fabio Schutz

Estudo 2 – Marcus Vinícius Sadi

ASCO GU 2022: Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Avelumab/Axitinib in Patients With Localized Renal Cell Carcinoma Who Are at High Risk of Relapse After Nephrectomy (NeoAvAx)

Estudo 3 – Thiago Souto Hemerly

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma

Parte 2 Discussão de casos

Comments are closed.